Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Opioids in cancer: The κ‑opioid receptor (Review)
Activation of opioid receptors in the enteric nervous system. MOR mu... | Download Scientific Diagram
κ-Opioid Receptor (KOP) | 7TM Antibodies
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Figure 2 from Development of κ opioid receptor antagonists. | Semantic Scholar
κ-opioid receptor - Wikipedia
Kinase cascades and ligand-directed signaling at the kappa opioid receptor. - Abstract - Europe PMC
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
κ-opioid receptor - Wikipedia
κ‑opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO‑1 pathway
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Antagonists of the kappa opioid receptor - ScienceDirect
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
